Our Locations

Flourish San Antonio began as Clinical Trials of Texas, LLC (CTT), in 2001 when Kay Scroggins, RN, founded what is now one of the largest and most well-respected clinical research sites in the U.S.

Flourish San Antonio has a long history of conducting large cohort vaccine studies and Phase I-IV studies in multiple therapeutic areas, and became one of the top 10 enrolling sites worldwide for the Pfizer COVID-19 vaccine study.

The Flourish Andersonville clinic began as Great Lakes Clinical Trials and served as the company’s flagship research center. It was founded in 2013 by Steve Satek, President and CEO, and currently employs over 30 full-time staff, including four investigators, and over a dozen research coordinators. The opening of the this location brought clinical trials to the north side of Chicago’, a traditionally underserved and diverse population of over 1.5 million.

Flourish Ravenswood provides the highest quality care and conducts studies in rheumatic diseases, metabolic disorders, COVID-19, and vaccines. The team includes Dr. Manish Jain, board-certified in both rheumatology and internal medicine, and a leading therapeutic expert in inflammatory conditions. The cornerstone of Dr. Jain’s practice is to provide honest, cutting-edge treatment suited to each individual, whether it be conservative therapy or a more aggressive approach. Flourish Ravenswood is a 2,200 square foot suite, specifically designed for a rheumatology clinical practice with an in-house infusion center.

Flourish Gurnee began as Great Lakes Clinical Trials, founded by Steve Satek, and serves the northern part of Lake County as well as southern Wisconsin. This outpatient clinic is 1,500 square feet and offers state-of-the-art clinical trials to better serve the needs of their patient community in northern Illinois and southern Wisconsin. Under the guidance of board-certified Internist, Dr. Eugene Bukhman, the center specializes in studies for metabolic disorders, vaccines, and Alzheimer’s disease.

Flourish Miami started out as Clinical Trials of Florida. Initially it conducted respiratory and sleep trials, later expanding into a Phase I-IV CNS, healthy, COVID-19, and vaccine trial site. Miami has also served as the central lab for complex Spirometry testing. Flourish Miami is led by Dr. Mark Rosenthal, a Family Practice physician board-certified in Sleep Medicine.

Flourish Orlando was initially founded as Florida Pulmonary Research Institute, specializing in Sleep and Pulmonary studies before expanding into a full Phase I-IV multi-specialty research (neurology, CNS, Gastro, cardiology, nephrology, women’s health, vaccines, healthy, internal medicine), site with PBMC lab capabilities. It is a global enrollment leader in respiratory, COVID-19, and sleep trials. Medical Director Dr. Faisal A. Fakih, is a board-certified Pulmonologist – a published, and highly respected Key Opinion Leader in the respiratory landscape. Dr. Fakih is also the Co-Founder of Flourish Orlando, along with Ana T. Marquez. Flourish Orlando has a team of Investigators in different specialties as well, including nephrology, neurology, cardiology, gynecology, pediatrics and more.

The Flourish Leesburg location was initially founded as Medical Research of Central Florida, conducting late phase respiratory trials. Today Flourish Leesburg has expanded capabilities to early phase trials, and is a multi-therapeutic site conducting studies in Gastroenterology, Nephrology, Vaccines, COVID-19, and respiratory studies. Flourish Leesburg is led by Dr. Jose Diaz, a board-certified pulmonologist.

Flourish Philadelphia began as Keystone Clinical Trials, founded in 2003 by Dr. Cherian Verghese and his brother, Tom Verghese as co-founder, and continued to grow the site after Tom passed away in 2019. The site conducts clinical trials for Alzheimer’s Disease, Parkinson’s Disease, and Depression. Dr. Verghese has been the Principal Investigator on over 130 clinical trials to date and has been instrumental in the FDA approval of medications in over 10 different indications.

Flourish Miami – Little Havana began as Suncoast Research Group in 2004. This large, multi-therapeutic site features depth in Flourish’s core therapeutic areas of Cardiology/Metabolic, CNS, and Vaccines. The site has 5 investigators, in-house beds for Phase 1, and onsite PBMC capabilities.

Founded by Marco Ramirez and Dr. Mark Kutner, the Flourish Miami – Little Havana site excels at reaching underserved minority communities. It also has experience in large-cohort vaccine studies across multiple indications.

Flourish Birmingham, Alabama began as Central Research Associates, founded by William Whitely, PharmD in 2016. The site has six investigators and conducts Phase II-IV studies across multiple therapeutic areas including cardiometabolic, pediatrics, orthopedics, and women’s health capabilities. This location is also a leading enroller in national vaccine studies. Flourish Birmingham is located on the campus of St. Vincent’s Hospital.

Flourish Charlotte, North Carolina began as AMC, founded by Reza Bolouri, MD, a board-certified neurologist. The site is an Alzheimer’s Center of Excellence for Flourish. Dr. Bolouri has more than 20 years of experience in clinical research for Alzheimer’s Disease and related dementias.

Flourish Los Angeles, formerly Valley Clinical Trials, is a leading clinical research site with three locations in Los Angeles County that specializes in cardiology, metabolic, and related therapeutic areas. With the acquisition, Flourish now has 15 sites across seven states. 

 Flourish Los Angeles was founded by Julie Toven, Christopher Chow, MD and Masoud Azizad, MD in 2010, and has rapidly grown into a leading multi-site clinical trials platform.  

The Flourish Bowie location was initially founded as Chesapeake Cardiac Care founded by Sara Collins, MD and Barbara Hutchinson, MD in 2003. The site expanded in 2023 to include clinical research and is now Flourish Bowie. The team at Flourish Bowie will be conducting cardiology studies under the leadership of Drs. Collins and Hutchinson.